Linhua Lan

Dr. Linhua Lan

The First Affiliated Hospital of Wenzhou Medical University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
FSFugen Shangguan
Fugen Shangguan
HZHongfei Zhou
Hongfei Zhou
NMNengfang Ma
Nengfang Ma
SWShanshan Wu
Shanshan Wu
HHHuimin Huang
Huimin Huang
LLLinhua Lan
Linhua Lan
Cannabidiol (CBD), a phytochemical derived from Cannabis sativa L., has been demonstrated to exhibit promising anti-tumor properties in multiple cancer types. However, the effects of CBD on hepatocellular carcinoma (HCC) cells remain unknown. We have shown that CBD effectively suppresses HCC cell growth in vivo and in vitro, and induced HCC cell pyroptosis in a caspase-3/GSDME-dependent manner. We further demonstrated that accumulation of integrative stress response (ISR) and mitochondrial stress may contribute to the initiation of pyroptotic signaling by CBD. Simultaneously, CBD can repress aerobic glycolysis through modulation of the ATF4–IGFBP1–Akt axis, due to the depletion of ATP and crucial intermediate metabolites. Collectively, these observations indicate that CBD could be considered as a potential compound for HCC therapy.

11 March 2024 in Cancer Letters
Verified
Journal Article
Closed access
HHHuimin Huang
Huimin Huang
SWShitong Wang
Shitong Wang
HXHongping Xia
Hongping Xia
XZXingling Zhao
Xingling Zhao
KCKaiyuan Chen
Kaiyuan Chen
LLLinhua Lan
Linhua Lan

25 January 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
DXDeyao Xie
Deyao Xie
XWXiaoyi Wu
Xiaoyi Wu
LLLinhua Lan
Linhua Lan
FSFugeng Shangguan
Fugeng Shangguan
XLXiaoming Lin
Xiaoming Lin
BLBIN LU
BIN LU
Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics

28 May 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
YLYongzhang Liu
Yongzhang Liu
LLLinhua Lan
Linhua Lan
KHKate Huang
Kate Huang
RWRongrong Wang
Rongrong Wang
CXCuicui Xu
Cuicui Xu
BLBin Lu
Bin Lu
ATP-dependent Lon protease within mitochondrial matrix contributes to the degradation of abnormal proteins. The oxidative or hypoxic stress which represents the stress phenotype of cancer leads to up-regulation of Lon. However, the role of Lon in bladder cancer remains undefined. Here, we found that Lon expression in bladder cancer tissues was significantly higher than those in noncancerous tissues; down-regulation of Lon in bladder cancer cells significantly blocked cancer cell proliferation via suppression c-Jun N-terminal kinase (JNK) phosphorylation due to decreased reactive oxygen species (ROS) production and enhanced the sensitivity of bladder cancer cells to chemotherapeutic agents by promoting apoptosis. We further found that Lon down-regulation in bladder cancer cells decreased cellular bioenergetics as determined by measuring aerobic respiration and glycolysis using extracellular flux analyzer. The tissue microarray (TMA) results showed that high expression of Lon was related to the T and TNM stage, as well as histological grade of bladder cancer patients. We also demonstrated that Lon was an independent prognostic factor for overall survival of bladder cancer. Taken together, our data suggest that Lon could serve as a potential diagnostic biomarker and therapeutic target for treatment of bladder cancer, as well as for prediction of the effectiveness of chemotherapy.

2 January 2021 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
DFDan Fang
Dan Fang
CZChengfei Zhang
Chengfei Zhang
PXPing Xu
Ping Xu
YLYinhua Liu
Yinhua Liu
XMXiao Mo
Xiao Mo
LLLinhua Lan
Linhua Lan

19 November 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XNXiaobo Nie
Xiaobo Nie
MLMin Li
Min Li
BLBin Lu
Bin Lu
YZYuxin Zhang
Yuxin Zhang
LLLinhua Lan
Linhua Lan
JLJianxin Lyu
Jianxin Lyu
The human mitochondrial ATP-dependent Lon protease functions in regulating the metabolism and quality control of proteins and mitochondrial DNA (mtDNA). However, the role of Lon in cancer is not well understood. Therefore, this study was undertaken to investigate the importance of Lon in cervical cancer cells from patients and in established cell lines. Microarray analysis from 30 cancer and 10 normal cervical tissues were analyzed by immunohistochemistry for Lon protein levels. The expression of Lon was also examined by immunoblotting 16 fresh cervical cancer tissues and their respective non-tumor cervical tissues. In all cases, Lon expression was significantly elevated in cervical carcinomas as compared to normal tissues. Augmented Lon expression in tissue microarrays did not vary between age, tumor-node-metastasis grades, or lymph node metastasis. Knocking down Lon in HeLa cervical cancer cells by lentivrial transduction resulted in a substantial decrease in both mRNA and protein levels. Such down-regulation of Lon expression significantly blocked HeLa cell proliferation. In addition, knocking down Lon resulted in decreased cellular bioenergetics as determined by measuring aerobic respiration and glycolysis using the Seahorse XF24 extracellular flux analyzer. Together, these data demonstrate that Lon plays a potential role in the oncogenesis of cervical cancer, and may be a useful biomarker and target in the treatment of cervical cancer. Lon; immunohistochemistry; cervical cancer; cell proliferation; cellular bioenergetics.